Sales rise 29.15% to Rs 24.72 crore
Net profit of Indo US Bio-Tech rose 33.76% to Rs 3.17 crore in the quarter ended June 2024 as against Rs 2.37 crore during the previous quarter ended June 2023. Sales rose 29.15% to Rs 24.72 crore in the quarter ended June 2024 as against Rs 19.14 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales24.7219.14 29 OPM %14.9315.62 -PBDT3.392.65 28 PBT3.192.45 30 NP3.172.37 34Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
